Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an Antibody-Drug Conjugate, in patients with advanced solid ...
Syngene is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical ...
Tim Davie became Director-General of the BBC on 1 September 2020. He is the 17th Director-General of the Corporation. Prior to this, Tim was Chief Executive of BBC Studios, the BBC’s principal ...
What will Pres­i­dent Don­ald Trump’s team do on health­care? No­body knows for sure.
Most trade below their debut price. Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the ...
Sir Tim Martin is considering opening Wetherspoon pubs overseas as he chafes against the high taxes in Britain. The founder and chairman of JD Wetherspoon said he was weighing up the possibility ...
The Angels and former All-Star shortstop Tim Anderson are in agreement on a minor league contract, reports Bob Nightengale of USA Today. He’ll be in camp with the Halos as a non-roster invitee ...
There's no doubt Tim McGraw’s daughter, Audrey McGraw, has inherited her parents’ musical talent. The country legend, 57, shared an Instagram video of his youngest daughter, 23, performing a ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ironwood Pharma (IRWD – Research Report) and Centessa Pharmaceuticals (CNTA – Research Report).
With the third episode of Season 7, “The Rookie” finally tied up a long-running loose end that dates all the way back to Season 2 — what the heck happened between Tim Bradford (Eric Winter ...
Read our privacy notice. Wetherspoon boss Tim Martin today blamed dinner party-loving politicians for the decline in the pub trade as he revealed the chain will have to shoulder £60 million in ...